Imperial College London

Dr Rob White

Faculty of MedicineDepartment of Infectious Disease

Non-Clinical Lecturer in Virology



+44 (0)20 7594 1124robert.e.white Website




308Norfolk PlaceSt Mary's Campus






BibTex format

author = {Correia, S and Palser, A and Elgueta, Karstegl C and Middeldorp, JM and Ramayanti, O and Cohen, JI and Hildesheim, A and Fellner, MD and Wiels, J and White, RE and Kellam, P and Farrell, PJ},
doi = {10.1128/JVI.00375-17},
journal = {Journal of Virology},
title = {Natural variation of Epstein-Barr virus genes, proteins and pri-microRNA},
url = {},
volume = {91},
year = {2017}

RIS format (EndNote, RefMan)

AB - Viral gene sequences from an enlarged set of about 200 Epstein-Barr virus (EBV) strains including many primary isolates have been used to investigate variation in key viral genetic regions, particularly LMP1, Zp, gp350, EBNA1 and the BART miRNA cluster 2. Determination of type 1 and type 2 EBV in saliva samples from people from a wide range of geographic and ethnic backgrounds demonstrates a small percentage of healthy white Caucasian British people carrying predominantly type 2 EBV. Linkage of Zp and gp350 variants to type 2 EBV is likely to be due to their genes being adjacent to the EBNA3 locus, which is one of the major determinants of the type 1/type 2 distinction. A novel classification of EBNA1 DNA binding domains named QCIGP results from phylogeny analysis of their protein sequences but is not linked to the type 1/type 2 classification. The BART cluster 2 miRNA region is classified into three major variants through SNPs in the pri-miRNA outside of the mature miRNA sequences. These SNPs can result in altered levels of expression of some miRNAs from the BART variant frequently present in Chinese and Indonesian nasopharyngeal carcinoma (NPC) samples. The EBV genetic variants identified here provide a basis for future more directed analysis of association of specific EBV variation with EBV biology and EBV associated diseases.IMPORTANCE Incidence of diseases associated with EBV varies greatly in different parts of the world. Relationships between EBV genome sequence variation and health, disease, geography and ethnicity of the host may thus be important for understanding the role of EBV in diseases and for development of an effective EBV vaccine. This paper provides the most comprehensive analysis so far of variation in specific EBV genes relevant to these diseases and proposed EBV vaccines. By focussing on variation in LMP1, Zp, gp350, EBNA1 and the BART miRNA cluster 2, new relationships to the known type 1/type 2 strains are demonstrated and novel classificati
AU - Correia,S
AU - Palser,A
AU - Elgueta,Karstegl C
AU - Middeldorp,JM
AU - Ramayanti,O
AU - Cohen,JI
AU - Hildesheim,A
AU - Fellner,MD
AU - Wiels,J
AU - White,RE
AU - Kellam,P
AU - Farrell,PJ
DO - 10.1128/JVI.00375-17
PY - 2017///
SN - 1098-5514
TI - Natural variation of Epstein-Barr virus genes, proteins and pri-microRNA
T2 - Journal of Virology
UR -
UR -
UR -
VL - 91
ER -